Dasatinib-Blinatumomab for Ph-Positive ALL
- PMID: 33503351
- DOI: 10.1056/NEJMc2033785
Dasatinib-Blinatumomab for Ph-Positive ALL
Comment in
-
Dasatinib-Blinatumomab for Ph-Positive ALL. Reply.N Engl J Med. 2021 Jan 28;384(4):384. doi: 10.1056/NEJMc2033785. N Engl J Med. 2021. PMID: 33503352 No abstract available.
Comment on
-
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.N Engl J Med. 2020 Oct 22;383(17):1613-1623. doi: 10.1056/NEJMoa2016272. N Engl J Med. 2020. PMID: 33085860 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources